Web based platform that enables powerful real world insights using customized post FDA approval drug data. Featuring RxCost® to determine direct costs of adverse events, RxSignal® for predictive notification of pending regulatory action, and RxScore® - a drug safety scorecard.
Custom advisory services to aid market access and commercialization strategies by using independent, real world data to support new drug launches, defend market position and help pharmaceutical companies tell their “drug safety story.”
Clean, standardized data architecture and straight forward APIs help power leading enterprise software applications and innovative IT companies that feed drug safety data into EHRs or third party applications.
Comparative safety research that provides safety reviews of new and soon-to-be launched drugs, insight into FDA safety communications, and contextual commentary on major drug safety issues. Complimentary Managed Care subscriptions.
Utilizing concise and detailed insight provided by Advera Health Analytics, your organization is able to gather and coordinate large amounts of information for pharmacy and therapeutics (P&T) class reviews, quantify the downstream medical cost of drug side effects and perform side-by-side in-class drug comparisons. The use of real world data to understand the true comparative nature of newly released drugs, provides the ability to monitor and react to external events such as FDA label changes and actions. Advera Health Analytics enables Comparative Effectiveness Research (CER) and the benchmarking of internal Adverse Drug Event (ADE) data against a global data set to determine if side effects are isolated or part of a trend. Additionally, it provides insight into total cost of care, including downstream medical costs that result from drug side effects.Learn more
Advera Health Analytics provides your organization with the highest quality, standardized and sourced real world drug data for a global scale perspective. Advera’s data, analytics and insight provides the ability to benchmark in-facility reported Adverse Drug Event (ADE) data to a global data set making it possible to know if adverse events are an isolated incident or a part of an emerging trend. Advera’s insights will enable you to quickly determine what needs immediate Pharmacy Department attention and what protocols need to be created or modified in light of any FDA label changes or actions.Learn more
Advera Health Analytics’ data and insight provides a complete understanding of the true comparative nature of drugs’ safety through access to statistical severity rankings and the ability to predict future regulatory action – critical information when positioning a drug to managed care. Advera’s tools provide detailed insight into emerging side effect trends for both your and your competitor’s products ensuring overall better planning and positioning, as well as more thorough due diligence for strategic investing and licensing. The knowledge of emerging side effect trends access to comparative assessments will enable you to appropriately position the risks and advantages of a particular candidate in today’s market and provide accurate and complete Comparative Effectiveness Research for the Pharmacy and Therapeutics (P&T) committees.Learn more
Utilizing simple to use and understand, statistical risk assessment analytics found in Advera Health Analytics’ products enables an enterprise-wide solution that provides you with a complete understanding of your life science business. By aggregating the risk from drug side effects, Advera is able to provide insight that reveals where risk exposure lies at the company and portfolio level, for example potential litigation, so vital when making underwriting decisions. The real world data, analytics and insight provided by Advera Health Analytics is insurance for your underwriting.Learn more
We live in a world where information is everything. But the ability to use real world data to provide differentiated research to clients has become extremely difficult. Advera Health Analytics has remedied this by developing exclusive analytics that provide quick access to post approval side effect data, creating an information advantage for you and your clients. Advera’s detailed insight also helps you generate new investment ideas, and modify existing positions – all based on the most complete compilation of real world drug data available.Learn more
RxCost® is the first standardized methodology to determine direct costs of adverse drug events, enabling decisions to be made based on total cost of care.
RxSignal® is a predictive algorithm that alerts users to emerging/previously unidentified side effect threats that may prompt a future FDA regulatory action.
Similar to a FICO credit score, RxScore® is the first drug safety scoring system that quickly summarizes comprehensive post-approval drug safety issues.